In glioblastoma treated with epidermal growth factor receptor inhibitors, drug resistance was mediated via amplification of AKT activity following a compensatory increase in insulin growth factor receptor signaling (Chakravarti et al., 2002). Here, EGFR is linked to glioblastoma.